• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Procter & Gamble Health Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 149.0
  • ISIN : INE199A01012
5,859.00 31 (0.53%)
  • As on 03 Nov 2026 (EOD)
  • Today’s Low

    5,684.50
  • Today’s High

    5,895.00
  • Open

    5,770.50
  • Perv Close

    5,828.00
  • 52W Low

    4,707.00
  • 52W High

    6,975.00

Key Indicators

  • P/E(TTM)

    29.18

  • Mar.Cap (₹Cr.)

    9,725.58

  • Div & Yield %

    3.50

  • Book Value(₹)

    316.01

  • Debt-Equity Ratio

    0.53

  • AGM Date

    03-Nov-2026

  • EPS

    200.73

  • P/E Ratio

    29.18

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    9,725.58

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    316.00

  • Sales( ₹ in Cr.)

    1,567.29

  • NP (in Cr.)

    328.30

  • NP Var(%)

    40.0

  • Div%

    2050.0

  • CPS (₹)

    212.00

  • EPS (₹)

    197.80

  • Traded Value (₹ in Lakhs)

    9,652.79

  • 52 Week High

    6,975.00

  • 52 Week Low

    4,707.00

  • Price BSE

    5815.0

  • Price NSE

    5,828.00

  • Market Capital( in Cr.)

    9,652.79

  • P/C Ratio

    27.40

  • P/E Ratio

    29.40

  • Price Vs.BV

    197.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Jun 2023 Jun 2022 Jun 2021 Jun
INCOME :            
Sales Turnover 1,567.29 1,029.07 1,151.26 1,229.62 1,114.41 1,008.73
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,567.29 1,029.07 1,151.26 1,229.62 1,114.41 1,008.73
Other Income 17.34 10.35 15.63 18.39 13.19 18.10
Stock Adjustments 12.83 -14.75 -0.87 -2.85 4.75 -1.73
Total Income 1,597.46 1,024.67 1,166.02 1,245.16 1,132.35 1,025.10
EXPENDITURE :            
Raw Materials 377.91 247.75 329.69 358.99 344.55 310.39
Power and Fuel Cost 7.33 5.82 8.50 12.88 14.70 12.97
Employee Cost 222.56 142.06 215.16 206.17 167.56 153.66
Other Manufacturing Expenses 106.16 55.91 83.99 90.86 98.43 90.82
Selling and Administration Expenses 387.77 230.88 181.66 196.86 203.91 173.99
Miscellaneous Expenses 21.73 13.51 45.58 36.33 22.33 19.15
Employee Benefit Expenses 222.56 142.06 215.16 206.17 167.56 153.66
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,123.46 695.93 864.58 902.09 851.48 760.98
Operating Profit 474.00 328.74 301.44 343.07 280.87 264.12
Interest 0.55 0.43 0.72 0.77 0.42 0.80
Gross Profit 473.45 328.31 300.72 342.30 280.45 263.32
Depreciation 23.59 16.69 27.40 28.10 27.08 30.04
Profit Before Tax 449.86 311.62 273.32 314.20 253.37 233.28
Current Tax 118.49 77.70 80.94 89.79 60.81 63.60
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 4.46 -0.49 -8.60 -5.06 0.04 -7.12
Reported Net Profit 326.91 234.41 200.98 229.47 192.52 176.80
Extraordinary Items -1.39 -0.10 -14.71 0.51 -0.40 -0.31
Adjusted Net Profit 328.30 234.51 215.69 228.96 192.92 177.11
Adjustment below Net Profit -0.70 -3.57 0.67 -1.84 0.70 0.42
P & L Balance brought forward 159.93 157.57 370.91 237.07 327.70 532.26
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 338.83 228.48 414.99 93.79 283.85 381.78
P & L Balance carried down 147.31 159.93 157.57 370.91 237.07 327.70
Dividend 265.58 132.80 331.99 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,050.00 1,250.00 2,600.00 950.00 525.00 1,300.00
Dividend Per Share(Rs) 205.00 125.00 260.00 95.00 52.50 130.00
Earnings Per Share-Unit Curr 196.93 188.28 121.07 138.23 115.98 106.51
Earnings Per Share(Adj)-Unit Curr 196.93 188.28 121.07 138.23 115.98 106.51
Book Value 315.99 323.47 324.24 452.34 371.38 423.92
Book Value(Adj)-Unit Curr 315.99 323.47 324.24 452.34 371.38 423.92

Shareholding Pattern

  • Promoter Group

    51.82%

  • Public Share Holding

    48.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 8,601,071 51.82 8,601,071 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 8,601,071 51.82 8,601,071 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 665 0.00 201 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,066,456 6.42 1,066,456 113
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 602,411 3.63 602,411 5
Mutual Funds / UTI 1,475,996 8.89 1,474,796 15
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 17,918 0.11 17,918 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,163,446 19.06 3,161,782 140
2] Non Institution
Bodies Corporate 398,851 2.40 395,886 459
Clearing Members 163 0.00 163 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 401,082 2.42 401,032 2,320
Foreign Non Institution Other 81 0.00 81 1
Hindu Undivided Families 91,903 0.55 91,903 1,175
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 300,929 1.81 300,929 7
Individuals holding nominal share capital up to Rs. 1 lakh 3,574,881 21.54 3,492,561 46,314
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,044 0.01 1,044 5
Others 65,931 0.40 65,931 1
Sub Total 4,834,865 29.13 4,749,530 50,285
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,599,382 100.00 16,512,383 50,426

Company Background

Procter & Gamble Health LtdPharmaceuticals - Multinational

  • Procter & Gamble Health Ltd
  • BSE Code : 149.0
  • ISIN : INE199A01012
  • Incorporation Year

    1967

  • Registered Office

    Godrej One 8th Floor
    Projshanagar Vikhroli (East), Mumbai,
    Maharashtra-400079

  • Telephone

    91-22-62109000

  • FAX

    91-22-62109999

  • Chairman

    MADHAVAN SAMPATH

  • Managing Director

    Milind Thatte

  • Company Secretary

    Zeal Shah

  • Auditor

    Haribhakti & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Procter & Gamble Health Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77